Compare Piramal Healthcare with Biocon Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs BIOCON - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

BIOCON  
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES BIOCON PIRAMAL ENTERPRISES/
BIOCON
 
P/E (TTM) x 16.7 29.9 55.9% View Chart
P/BV x 1.1 3.9 29.8% View Chart
Dividend Yield % 2.0 0.3 790.4%  

Financials

 PIRAMAL ENTERPRISES   BIOCON
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
BIOCON
Mar-19
PIRAMAL ENTERPRISES/
BIOCON
5-Yr Chart
Click to enlarge
High Rs3,303707 466.9%   
Low Rs1,797554 324.4%   
Sales per share (Unadj.) Rs716.591.9 779.6%  
Earnings per share (Unadj.) Rs79.716.7 477.0%  
Cash flow per share (Unadj.) Rs107.924.2 446.4%  
Dividends per share (Unadj.) Rs28.001.00 2,800.0%  
Dividend yield (eoy) %1.10.2 692.5%  
Book value per share (Unadj.) Rs1,477.5101.6 1,453.8%  
Shares outstanding (eoy) m184.45600.00 30.7%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x3.66.9 51.9%   
Avg P/E ratio x32.037.7 84.8%  
P/CF ratio (eoy) x23.626.1 90.6%  
Price / Book Value ratio x1.76.2 27.8%  
Dividend payout %35.16.0 587.0%   
Avg Mkt Cap Rs m470,292378,330 124.3%   
No. of employees `0007.86.1 127.5%   
Total wages/salary Rs m22,50411,653 193.1%   
Avg. sales/employee Rs Th16,899.48,994.3 187.9%   
Avg. wages/employee Rs Th2,877.71,900.7 151.4%   
Avg. net profit/employee Rs Th1,879.91,635.3 115.0%   
INCOME DATA
Net Sales Rs m132,15355,144 239.7%  
Other income Rs m3,1281,444 216.6%   
Total revenues Rs m135,28156,588 239.1%   
Gross profit Rs m66,29015,883 417.4%  
Depreciation Rs m5,2024,478 116.2%   
Interest Rs m44,097709 6,219.7%   
Profit before tax Rs m20,11912,140 165.7%   
Minority Interest Rs m3,1949 35,486.7%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,6112,123 405.6%   
Profit after tax Rs m14,70110,026 146.6%  
Gross profit margin %50.228.8 174.2%  
Effective tax rate %42.817.5 244.8%   
Net profit margin %11.118.2 61.2%  
BALANCE SHEET DATA
Current assets Rs m122,74248,228 254.5%   
Current liabilities Rs m310,81030,376 1,023.2%   
Net working cap to sales %-142.332.4 -439.6%  
Current ratio x0.41.6 24.9%  
Inventory Days Days2368 33.8%  
Debtors Days Days3986 45.4%  
Net fixed assets Rs m116,90464,130 182.3%   
Share capital Rs m3693,000 12.3%   
"Free" reserves Rs m272,16157,980 469.4%   
Net worth Rs m272,53060,980 446.9%   
Long term debt Rs m270,19615,766 1,713.8%   
Total assets Rs m856,261121,924 702.3%  
Interest coverage x1.518.1 8.0%   
Debt to equity ratio x1.00.3 383.5%  
Sales to assets ratio x0.20.5 34.1%   
Return on assets %6.98.8 78.0%  
Return on equity %5.416.4 32.8%  
Return on capital %12.416.8 74.1%  
Exports to sales %028.1 0.0%   
Imports to sales %018.9 0.0%   
Exports (fob) Rs mNA15,506 0.0%   
Imports (cif) Rs mNA10,399 0.0%   
Fx inflow Rs m15,20015,506 98.0%   
Fx outflow Rs m4,88910,399 47.0%   
Net fx Rs m10,3125,107 201.9%   
CASH FLOW
From Operations Rs m-115,97511,546 -1,004.5%  
From Investments Rs m-8,265-7,138 115.8%  
From Financial Activity Rs m107,525-2,417 -4,448.7%  
Net Cashflow Rs m-16,6502,103 -791.7%  

Share Holding

Indian Promoters % 52.9 40.4 130.9%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 4.0 8.4 47.6%  
FIIs % 26.6 10.7 248.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 19.9 82.9%  
Shareholders   93,274 109,995 84.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   DR. DATSONS LABS  DISHMAN PHARMA  FULFORD INDIA  JUBILANT LIFE SCIENCES  AJANTA PHARMA  

Compare PIRAMAL ENTERPRISES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Extend Gains; M&M and Hero MotoCorp Surge Over 4%(12:30 pm)

Share markets in India have extended early gains and are presently trading higher, tracking gains in Asian peers and Wall Street.

Related Views on News

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY20); Net Profit Up 11.7% (Quarterly Result Update)

Feb 5, 2020 | Updated on Feb 5, 2020

For the quarter ended December 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 11.7% YoY). Sales on the other hand came in at Rs 38 bn (up 9.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, BIOCON has posted a net profit of Rs 3 bn (down 30.5% YoY). Sales on the other hand came in at Rs 16 bn (up 19.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY20); Net Profit Up 16.5% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 16.5% YoY). Sales on the other hand came in at Rs 36 bn (up 14.6% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

More Views on News

Most Popular

This is How You Should Trade Intraday(Fast Profits Daily)

Jun 19, 2020

In this video, I'll show you how to trade the market intraday like a professional trader.

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

This Ratio Says Smallcaps Are Your Best Bet to Ride the Post Covid Market Rebound(Profit Hunter)

Jun 23, 2020

Here's why I believe that post Covid rebound in smallcaps will be much sharper than largecaps.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Jul 2, 2020 01:47 PM

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES - SUN PHARMA COMPARISON

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS